glp-1 intracranial hypertension The effect of glucagon-like peptide-1 agonists on ocular parameters in idiopathic patients: a retrospective study Recurrent Idiopathic Intracranial Hypertension–Related Papilledema

Data on the number of people in the US taking glucagon-like peptide-1 medications, both to reduce obesity and to help control diabetes, show a somewhat stable trend

In recent years, a spotlight has been placed on glucagon-like peptide-1 (GLP-1) receptor agonists for their promising effects on metabolic health, weight management, and even immune system regulation

Obes Rev 2024

Its Not Your Fault: The Truth About the Obesogenic Environment We are not living in the same world our grandmothers did

Is flexible dieting better than strict dieting Yes, flexible dieting is more sustainable and effective long-term.

[DOI] [PMC free article] [PubMed] [Google Scholar] 132.Rodriguez J.A., Fehrentz J.A., Martinez J., Ben Haj Salah K., Wellman P.J